Mental health & HIV — your mind matters as much as your labs.

There is a moment familiar to a lot of people living with HIV. The labs come back beautiful. Viral load undetectable. CD4 climbing. Everyone says you're doing great. And you walk out to the parking lot and sit in the car, because you cannot think of a single reason to drive anywhere.

Nothing about that is a failure of gratitude, and nothing about it is rare. Mental health has been measured alongside HIV since the mid-1990s, and every large study since has landed in the same place: depression, anxiety, and trauma-related conditions occur in people living with HIV at rates several times higher than in the general adult population. They also respond to treatment — and untreated, they measurably damage the rest of your HIV care.

This is a medical condition, not a character flaw

Depression after an HIV diagnosis is frequently described — by well-meaning friends, sometimes by clinicians — as an understandable reaction you will process and move past. Sometimes that's true; grief after a diagnosis is normal and self-limiting for many people.

But clinical depression is not the same thing as grief, and treating one as the other is how years get lost. HIV.gov describes depression as one of the most common mental health conditions that people living with HIV face, and lists the reasons it clusters here: the diagnosis itself can challenge your sense of well-being; disclosure decisions generate ongoing stress; HIV and opportunistic infections can affect the nervous system directly; HIV-related conditions and some HIV medications can both contribute; and not taking your medication can worsen depression, which makes it harder to take your medication.11

Read that last clause again. This is a loop, not a line: depression reduces the odds you take your pills, reduced adherence raises your viral load, and a rising viral load produces exactly the fear and self-blame that deepen depression. The loop runs both directions, which is also the good news — interrupt it anywhere and both sides improve.

Four things worth knowing before you read further

• There is no blood test for this. No biological or laboratory test diagnoses a mental health condition; diagnosis rests on structured questions, history, and ruling out medical causes.5
• Being undetectable does not make you immune. The largest recent U.S. survey of adults with diagnosed HIV found substantial depression across the board, including among people fully engaged in care.2
• Recovery is a normal outcome. HIV.gov states plainly that many mental health conditions are treatable and that many people with mental health conditions recover completely.11
• Your HIV clinic is the right front door. Not the only one, but usually the fastest — because the funding and the staff are frequently already there.10

The numbers — what four decades of data actually show

The foundational U.S. study is still worth naming. In 2001, Bing and colleagues published results from the HIV Cost and Services Utilization Study — a nationally representative probability sample of 2,864 adults receiving HIV care in the United States in 1996. Screening for major depression, dysthymia, generalized anxiety disorder, and panic attacks, they found nearly half screened positive for a psychiatric disorder. Nearly 40% reported using an illicit drug other than marijuana, and more than 12% screened positive for drug dependence in the previous twelve months. The factors most associated with those findings were the number of HIV-related symptoms, drug use, drug dependence, heavy alcohol use, and being unemployed or disabled. The authors' conclusion was a call to action: actively identify people at risk for these treatable disorders.1 That was 1996 data — before single-tablet regimens, before undetectable-equals-untransmittable. So what happens when you re-measure in the treatment era?

Depression today: about one in three

The CDC's Medical Monitoring Project surveys a nationally representative sample of adults with diagnosed HIV. In the 2021 cycle, combining PHQ-8 symptom screening with medical record review across 23 jurisdictions and 3,928 respondents, researchers found 34% had any depression — either current symptoms or a documented diagnosis. About 15% had current symptoms of major or other depression, and 25% had a depression diagnosis in their record.2

The breakdown inside that 34% is the part clinicians should be reading. Of everyone with any depression, 26.1% were undiagnosed — symptoms, nothing in the chart. Another 18.9% were diagnosed and still symptomatic, and 55.0% were diagnosed without current symptoms, which is roughly what successful treatment looks like.2

Anxiety: nearly one in five, against a general-population rate of 2.7%

The clearest anxiety comparison also comes from the Medical Monitoring Project. Using the GAD-7 with a cutoff of 10 in 3,654 adults with diagnosed HIV, CDC investigators found 19.2% had generalized anxiety disorder symptoms — nearly one in five — compared with a past-year GAD prevalence of 2.7% among U.S. adults generally.3

The subgroup numbers are stark, and almost entirely about circumstance rather than virology. GAD symptoms reached 33.3% among people experiencing homelessness, 32.6% among people with any disability (versus 7.9% without — a prevalence ratio of 4.14), and 42.8% among those reporting sexual violence in the past year.3 One finding deserves quoting in every stigma conversation: the median HIV-related stigma score was 55 among people with GAD symptoms versus 35 among those without.3 Stigma is not a feeling. It is a measurable exposure with measurable psychiatric consequences.

Trauma, mortality, and the women's cohort data

PTSD is the third leg, and it is badly under-screened. Among women with HIV in the United States, pooled estimates put PTSD prevalence at roughly 30% — about five times the rate among women without HIV.5

The Women's Interagency HIV Study — the long-running U.S. cohort of women living with HIV, now part of the MACS/WIHS Combined Cohort Study — supplies the most sobering finding in this field. Following 818 women over 3,292 woman-years, investigators measured not whether depression was present but how long it lasted. Each additional 365 days spent with depression was associated with a 72% increase in the risk of all-cause mortality (hazard ratio 1.72; 95% CI 1.34–2.20), dose-dependently — 182 days carried a hazard ratio of 1.31, 91 days 1.14 — with no evidence that receiving antiretroviral therapy blunted it.4 Earlier WIHS work established the baseline burden: 57.7% of women living with HIV screened above the standard CES-D cutoff.4

Read alongside the CDC viral suppression data, the message is not subtle. Duration of untreated depression is itself the exposure, so treating it sooner is not a nicety layered on top of HIV care — on this evidence it belongs inside it.

Screening — the four questionnaires, and what to say if nobody asks

Screening in HIV care is not supposed to be optional. The HIV Medicine Association and Infectious Diseases Society of America primary care guidance recommends screening people with HIV for depression at least annually using the PHQ-9, and screening for anxiety at initial evaluation and annually using the GAD-7 or GAD-2.5 The U.S. Preventive Services Task Force separately gave adult depression screening a Grade B recommendation in June 2023, along with anxiety screening for adults under 65.5 Knowing the instruments helps: they are short, they are not tests you can fail, and understanding the numbers makes the conversation easier.

If your provider isn't screening you

Plenty of clinics don't, or do it inconsistently, or hand you a form nobody reads back to you. You are allowed to open the subject yourself, and you don't need clinical vocabulary: "I want to talk about my mood, not just my labs. For the last several weeks I've had [no interest in anything / trouble sleeping / constant worry / thoughts I don't like]. Can we do a PHQ-9 and a GAD-7 today, and can you tell me what mental health services this clinic can connect me to?"

Two practical notes. Ask for the numbers, not just the impression — a documented PHQ-9 score creates a baseline that makes the next visit easier. And if depression or anxiety is new, expect your provider to check for medical mimics: thyroid function, B12, testosterone, sleep apnea, anemia, and a review of every medication you take. That is not being dismissed; that is being worked up properly.5

Therapy — what has evidence, and how HIV clinics pay for it

Psychotherapy for depression is one of the better-studied interventions in medicine, and the American Psychological Association's 2019 clinical practice guideline recommends seven distinct psychotherapies for adults: behavioral therapy, cognitive therapy, cognitive behavioral therapy, interpersonal psychotherapy, mindfulness-based cognitive therapy, psychodynamic therapy, and supportive therapy.7 That list dismantles the idea that there is one correct therapy. Course lengths varied widely — CBT typically 6 to 20 weekly sessions, interpersonal psychotherapy 16 to 20, mindfulness-based cognitive therapy eight weekly two-hour group sessions, behavioral therapy averaging 20 to 24.7 If one approach doesn't fit you, six others carry recommendations.

The HIV-specific trial: CBT-AD

What makes HIV distinctive is that depression treatment has been tested here with adherence as a co-target. In a three-arm randomized controlled trial published in The Lancet HIV in 2016, Safren and colleagues randomized 240 adults with HIV and depression across three New England HIV clinics to cognitive behavioral therapy for adherence and depression (CBT-AD), an information and supportive psychotherapy comparison (ISP-AD), or enhanced treatment as usual.6

CBT-AD ran 11 to 12 modules: motivational interviewing, increasing pleasurable activities with mood monitoring, roughly five sessions of cognitive restructuring, problem-solving, relaxation training, and "Life-Steps" adherence counseling.6 Against enhanced treatment as usual, CBT-AD produced 7.55 percentage points better ART adherence at month 4 (95% CI 1.42–13.67; p=0.016) and 8.93 points at follow-up (1.90–15.97; p=0.013), alongside a 3.56-point improvement in CES-D depression scores (p=0.005) and a 4.69-point improvement on the Montgomery-Åsberg scale at month 4 (p=0.007), with no study-related adverse events.6

Two honest caveats from the same paper. CBT-AD was not superior to the supportive psychotherapy comparison arm for either adherence or depression — structured attention from a trained clinician did a great deal of the work. And gains waned after treatment ended, declining roughly 4.5 to 4.8 points per subsequent visit.6 Neither arm changed HIV RNA or CD4 count.

Other approaches you'll hear named

Dialectical behavior therapy (DBT) was developed for chronic suicidality and emotion dysregulation, centering skills in distress tolerance, emotion regulation, interpersonal effectiveness, and mindfulness. Acceptance and commitment therapy (ACT) works on psychological flexibility — making room for difficult thoughts rather than fighting them, and acting on values anyway. Both are widely used in HIV and LGBTQ+ health settings. Neither appears among the APA guideline's seven psychotherapies, which does not mean they don't work — it means that evidence review for adult depression didn't recommend them.7 For trauma, ask specifically about trauma-focused modalities rather than general talk therapy.

Who pays: the Ryan White answer

This is the part most people don't know, and it may be the single most useful fact on this page. Under the Ryan White HIV/AIDS Program, mental health services and substance abuse outpatient care are listed core medical services — the same category as outpatient medical care, medical case management, oral health, and the AIDS Drug Assistance Program.10 Support services additionally include psychosocial support, residential substance abuse services, housing, legal services, medical transportation, food assistance, and emergency financial assistance.10

Eligibility is straightforward: a diagnosis of HIV or AIDS, low income as defined where you live, and either no insurance or insurance that doesn't pay for the care you need.10 Program design varies by grantee, so the practical question is: "Does this clinic have a behavioral health provider on staff, and if not, who do you refer Ryan White clients to?"

Finding someone who is actually a good fit

• Ask your HIV clinic first. A therapist who already works with PLHIV will not need you to explain undetectable viral load, disclosure, or U=U.
• Ask about LGBTQ+ affirming practice explicitly — not "are you comfortable with," but what training they have and what proportion of their caseload is LGBTQ+.
• Use the free federal locators. HIV.gov points to SAMHSA's treatment locator, MentalHealth.gov, and NIMH resources.11
• Give it three sessions, then decide. Fit is a legitimate clinical variable; leaving a therapist who isn't right is not failing at therapy.

Medication — and the ART interaction question, answered

The APA guideline recommends second-generation antidepressants — SSRIs, SNRIs, or NDRIs — for adult depression while stating clearly that the evidence base is insufficient for recommending any specific medication over another.7 Medications and dose ranges named for adults include sertraline 50–200 mg, escitalopram 10–20 mg, fluoxetine 10–80 mg, citalopram 20–40 mg, paroxetine 20–40 mg, bupropion 150–450 mg, venlafaxine 75–300 mg, duloxetine 40–60 mg, mirtazapine 15–45 mg, trazodone 150–400 mg, and vortioxetine 10–20 mg.7 Because no single agent wins on evidence, prescribers choose on side effects, timing, cost, other conditions you have, and — in HIV care — interactions. Which brings us to the fear that stops many people before they start.

Where interactions genuinely live

Interactions concentrate in two places: boosted protease inhibitors (ritonavir- or cobicistat-boosted atazanavir and darunavir) and certain non-nucleoside reverse transcriptase inhibitors, chiefly efavirenz. The DHHS tables give specifics, not vague warnings.8

• Efavirenz reduces bupropion exposure by 55% and sertraline exposure by 39%; the guidance is to titrate the dose based on clinical response rather than to avoid the combination. Paroxetine with efavirenz needs no dose adjustment.8
• Boosted darunavir lowers paroxetine exposure by 39% and sertraline by 49%; SSRIs with boosted PIs are titrated from the lowest available starting dose.8
• Trazodone with a boosted PI raises trazodone exposure by 240% — start at the lowest dose and monitor.8
• Doravirine and rilpivirine show "no dose adjustment needed" with bupropion, citalopram, escitalopram, paroxetine, and sertraline.8
• St. John's wort should be avoided with several antiretrovirals — this is one of the few genuine do-not-combine situations, and it is sold over the counter.8

Notice the pattern: almost every entry says titrate and monitor, not do not use. The clinical task is dose attention, not abstinence.

The free tool to check anything

The University of Liverpool's HIV Drug Interactions service is the reference most HIV clinicians use, it is free, and you can use it yourself. Its checker returns a traffic-light result — do not coadminister, potential interaction, potential weak interaction, or no interaction expected — with a grade for evidence quality.9 The site also publishes dated prescribing resources by indication, including antidepressants, antipsychotics, anxiolytics and hypnotics, gender affirmation therapies, and prescribing for older people living with HIV.9

When HIV medication is the problem

Sometimes the antiretroviral itself is contributing, and the guidelines say so. Rilpivirine can exacerbate psychiatric symptoms and may be associated with suicidality, and the DHHS guidelines advise considering avoiding rilpivirine-based regimens in people with psychiatric illness. Efavirenz's neuropsychiatric effects and suicidality are cited as reasons it is no longer recommended for initial therapy. Neuropsychiatric adverse events have been reported with integrase inhibitors — though large trials and database analyses found similar rates between dolutegravir-based regimens and comparators, serious events were uncommon at under 1% with bictegravir, and they rarely led to discontinuation, clustering where they did occur in people with preexisting depression, other psychiatric illness, or a prior suicide attempt. The guidelines' instruction: people on integrase-based regimens with preexisting psychiatric conditions should be closely monitored.8

So if your mood shifted sharply within weeks of a regimen change, say so, and say when. That is a reportable, actionable observation — not a coincidence to keep to yourself. HIV.gov likewise notes some antiretrovirals can cause depression, anxiety, and sleep disturbance.11

Peer support — the intervention with no side effects

Peer support is not a consolation prize for people who can't get therapy. It does something clinical care structurally cannot: it puts you in a room with people who already know the parts you would otherwise have to explain.

SAMHSA treats this as a core principle rather than an extra. In its trauma-informed framework, peer support and mutual self-help are named as key vehicles for establishing safety and hope, building trust, enhancing collaboration, and using lived experience to promote recovery and healing.14 Ryan White reinforces it on the funding side, where psychosocial support services sit in the support services category.10 The mechanism is not mysterious: CDC data show HIV-related stigma scores were dramatically higher among people with anxiety symptoms, and experiencing discrimination in an HIV care setting was itself associated with higher depression prevalence — 42.7% versus 32.0%.32 Isolation is part of the injury. Company is part of the repair.

Where to look

• Your HIV clinic or AIDS service organization. HIV.gov advises asking your HIV provider, patient navigator, or case worker about both mental health support groups and HIV support groups — these are usually the fastest route to something local and free.11
• Peer navigation programs. Many Ryan White clinics employ peers living with HIV in navigation roles — and a peer navigator can accompany you to appointments.
• Long-term survivor circles. Distinct from newly-diagnosed groups, with distinct content — see long-term survivors.
• Community publications. POZ, Positively Aware, and TheBody have carried first-person mental health writing by people living with HIV for decades. They are not clinical sources, but reading someone describe your own experience in print does something no guideline does.

One caution: a group whose culture is despair, or where disclosure isn't protected, can leave you worse. Try more than one. Leaving a group is allowed.

Crisis — what to do in the moment

If you are thinking about ending your life, or you are frightened by your own thoughts, skip the rest of this page.

What a 988 call is and isn't

The most common reason people don't call is a fear that any call ends with police at the door. To be accurate: the overwhelming majority of 988 contacts resolve on the phone or in chat with a trained counselor, and you control how much you disclose. You can call about something short of an emergency — that is what it is for.

You should also know about a real change in the service. A pilot launched in 2022 let LGBTQI+ people under 25 reach affirming support through 988 by calling and pressing #3, texting "PRIDE" to 988, or selecting an LGBTQI+ option in a pre-chat survey; the subnetwork was formalized in 2023. On June 17, 2025, SAMHSA announced its closure, effective July 17, 2025.12 The main 988 line remains fully operational, and Trans Lifeline and The Trevor Project continue to operate independently.13 If you see older material referencing "Press 3," that is why it may not work.

A safety plan, written before you need it

• Warning signs. Your own specific early ones — not sleeping, cancelling on people, skipping doses, drinking more.
• Two people you can call, by name, with numbers saved in your phone.
• One professional contact. Your clinic's after-hours line, your therapist, or 988 as the default.
• Means safety. If there are firearms or stockpiled medications in your home, distance between you and them during a bad stretch measurably matters.
• Three things that have helped before. Specific and small — not aspirations.

If you support someone living with HIV, ask directly. Asking about suicidal thoughts does not plant them, and the PHQ-9 asks the same question in writing every year for that reason.5

Trauma-informed care — what it looks like when it's real

SAMHSA defines a trauma-informed program, organization, or system as one that "realizes the widespread impact of trauma and understands potential paths for recovery; recognizes the signs and symptoms of trauma in clients, families, staff, and others involved with the system; and responds by fully integrating knowledge about trauma into policies, procedures, and practices, while seeking to actively resist retraumatization."14

The guiding principles SAMHSA names are safety; peer support; trustworthiness and transparency; collaboration and mutuality, including leveling power differences between staff and the people they serve; and empowerment, voice, and choice.14 This matters acutely in HIV care because the trauma exposure data are so high. In CDC's depression analysis, any depression was present in 53.1% of people reporting lifetime sexual violence versus 30.1% of those without, 66.6% of those reporting sexual violence in the past year, and 55.7% of those reporting intimate partner violence in the past year.2 These are not edge cases in an HIV clinic waiting room.

Signs your care is trauma-informed

• Someone explains what will happen before it happens — including exams, blood draws, and who will read your chart.
• You are asked permission rather than instructed, and "not today" is an acceptable answer.
• Missed appointments produce outreach and curiosity, not lectures.
• Substance use, sex, and sex work can be discussed factually without a change in the room's temperature.
• Your pronouns and name are used correctly by the front desk, not just the clinician.

Signs it isn't

• Adherence discussed as a moral test rather than as a question of what got in the way.
• Details of your sexual history requested with no clinical purpose stated, or your diagnosis discussed where others can hear it.
• Disclosure of trauma met with a change of subject, or with pressure to tell the whole story on the spot.
• Every problem reframed as your motivation, never as transportation, housing, cost, work schedules, or the clinic's own hours.

You can name this out loud: "I have a trauma history and some of this is hard for me. It helps when you tell me what's coming before you do it." A clinic worth staying at will adjust. One that doesn't has given you information.

Substance use and mental health — why splitting them apart fails

The overlap was visible in the earliest national data. In the 1996 HCSUS sample, nearly 40% reported using an illicit drug other than marijuana and more than 12% screened positive for drug dependence in the previous year — alongside the roughly half who screened positive for a psychiatric disorder. Drug use, drug dependence, and heavy alcohol use were among the factors most associated with psychiatric screening results.1 Current CDC data show the same coupling from the other direction: current smoking was reported by 50.6% of people with GAD symptoms versus 32.2% of those without.3 When three conditions share the same person, three separate treatment plans in three separate buildings is a structural problem, not a personal one.

SAMHSA's advisory on treating substance use disorders among people with HIV — the successor to the agency's long-standing HIV treatment improvement protocol — exists precisely to address integrated care, and a companion SAMHSA guide reviews interventions for people with substance use and mental disorders who are at risk for or living with HIV, aligned with the federal Ending the HIV Epidemic initiative.15

What integrated care means in practice

• One team, or at minimum one shared record. Your HIV provider, prescriber, and substance use clinician should be able to see the same medication list.
• No sequencing requirement. Being told to sober up before mental health treatment will start is not evidence-based care, and that framing is stigmatizing on its face. Both are treated together.
• Ryan White covers both. Substance abuse outpatient care is a core medical service; residential substance abuse services sit in support services.10
• Interactions get checked once, across everything. Liverpool publishes dated prescribing resources covering antiretrovirals with recreational and chemsex drugs.9

Our companion page on HIV and substance use goes deeper on harm reduction, medications for opioid and alcohol use disorder, and finding non-judgmental care.

Brain fog — depression, HAND, or something else?

Trouble finding words. Losing the thread mid-sentence. Reading a paragraph three times. This is one of the most common and most frightening complaints in HIV care, partly because of what people living with HIV remember about AIDS dementia. The diagnostic framework is the Frascati criteria, published in Neurology in 2007 by Antinori and colleagues on behalf of a working group convened with NIMH and NINDS support. It updated the 1991 American Academy of Neurology criteria, introduced the category of asymptomatic neurocognitive impairment, and proposed a diagnostic algorithm — noting candidly that it represented a majority view rather than unanimity on all points.16

The three tiers

• Asymptomatic neurocognitive impairment (ANI): performance at least 1 standard deviation below the mean in at least two cognitive domains, with no overt functional impairment.17
• Mild neurocognitive disorder (MND): the same testing threshold plus overt, usually mild, functional impairment.17
• HIV-associated dementia (HAD): at least 2 standard deviations below the mean in at least two domains, with functional impairment affecting activities of daily living.17

The treatment era changed the distribution dramatically. Post-HAART, reported prevalences run approximately 33% for ANI, 12% for MND, and 2% for HAD — against early-epidemic estimates in which HIV-associated dementia affected as many as 40% of people with advanced disease. In the CASCADE collaboration, incidence fell from 6.49 to 0.66 per 1,000 person-years.17

The DHHS guidelines add the aging picture: age-related decline in neurocognitive function is faster in people with HIV, cognitive impairment is associated with reduced adherence and poorer outcomes including increased risk of death, and referral to a neurologist, neuropsychologist, or geriatrician may be warranted for progressive impairment. The guidelines also name hearing impairment, diabetes, obesity, hypertension, depression, smoking, substance use, and limited physical and social activity as modifiable dementia risk factors — all common in older people living with HIV.8

Practically: ask for a workup rather than reassurance — formal neuropsychological testing, a depression and sleep assessment, thyroid and B12 labs, a medication review, and a cardiovascular risk assessment. Our page on HIV, fatigue, and brain fog covers it in more detail.

Tele-mental health — what the rules are in 2026

For a lot of people living with HIV, telehealth is the difference between having a therapist and not having one — no transportation, no waiting room, no running into a neighbor in an HIV clinic lobby, and access to specialists in HIV and LGBTQ+ mental health who may not practice within driving distance. Ordinary psychotherapy by video or phone is not federally restricted in the way many people assume. The complexity is specific to controlled substances — benzodiazepines, stimulants, ketamine, buprenorphine — because those prescriptions historically required an in-person evaluation.

On December 31, 2025, the DEA issued a fourth temporary extension of the COVID-19 telemedicine flexibilities for prescribing controlled medications, extending them through December 31, 2026. Under that extension, DEA-registered practitioners may remotely prescribe Schedule II–V controlled medications via audio-video telemedicine, and Schedule III–V narcotic controlled medications via audio-only telemedicine when the medication is FDA-approved for maintenance or withdrawal management of opioid use disorder. Prescriptions may be issued without a prior in-person evaluation, but must comply with DEA guidance and regulations and with applicable federal and state law.18

Two final rules published January 17, 2025 and effective December 31, 2025 — one expanding buprenorphine treatment via telemedicine, one on continuity of care via telemedicine for VA patients — sit alongside the extension as separate authorities. DEA framed the extension around continuity of care for people in rural and underserved areas, older adults, and people with limited mobility.18

Practical points

• State law still applies. Federal flexibility does not override state rules; your clinician generally must be licensed where you are physically located at the time of the visit.18
• Video versus audio-only. Video is the broader authority for controlled prescriptions; audio-only is narrower — if you don't have reliable video, say so when you book.18
• Deadlines move. This is the fourth extension. If you rely on a telehealth controlled prescription, ask your prescriber what the backup plan is.18
• Privacy at home is a real problem. Headphones, a parked car, a walk with earbuds — therapists are used to all of it. If home is genuinely unsafe for talking, ask whether your clinic has a private room you can use.

If you can't afford therapy

Cost is the most common reason people stop before starting, and it is solvable more often than people expect. In CDC's data, unmet need for mental health services among people with any need was 42.5% in the undiagnosed-depression group — evidence that the gap is access, not desire.2

Other routes worth trying

• 211. Dial 2-1-1 from anywhere in the U.S. for a local referral specialist who knows which agencies have openings and sliding scales this month.
• Community mental health centers. Publicly funded, obligated to serve people regardless of ability to pay, and they take Medicaid. Waits can be long; get on the list while pursuing other options.
• University training clinics. Doctoral programs in clinical psychology, counseling, and social work run low-fee clinics staffed by closely supervised trainees, often $10–$40 per session.
• Federally qualified health centers. Sliding fees by federal requirement, and many have behavioral health integrated into primary care.
• Intensive outpatient programs (IOP). If symptoms are severe, an IOP is often more accessible through insurance than weekly outpatient therapy, because medical necessity is easier to document.
• SAMHSA's national helpline and treatment locators, which HIV.gov points to for finding mental health and substance use care.11

Who carries the heaviest load

The disparities in HIV mental health data are almost entirely disparities of circumstance, not biology — and they are large enough that averages hide them.

Transgender people living with HIV

In CDC's 2021 depression data, 57.0% of transgender respondents had any depression (95% CI 46.8–67.2) — the highest of any group reported, against 38.2% of cisgender women and 32.2% of cisgender men.2 In the anxiety analysis, 22.9% of transgender respondents had GAD symptoms.3

Gender-affirming care and mental health care are not separate projects, and Liverpool publishes a dated prescribing resource covering gender affirmation therapies alongside antiretrovirals, so hormone-ART interaction questions have a real answer rather than a shrug.9 Trans Lifeline, at 877-565-8860, is peer support run by and for trans people — a meaningful distinction after the closure of 988's LGBTQI+ subnetwork.1312

Black people living with HIV — and where the burden actually sits

The CDC depression data contain a finding that is frequently misread. By race and ethnicity, any depression was reported by 40.4% of White respondents, 31.7% of Black respondents, and 30.7% of Hispanic/Latino respondents.2 Taken alone, that could be misused to suggest Black PLHIV are doing better. The same dataset shows where the burden concentrates: any depression was present in 49.1% of people with any disability versus 24.0% without; 53.2% of people experiencing food insecurity versus 30.6%; 47.0% of people with unstable housing or homelessness versus 31.5%; 41.0% of people at or below poverty; and 43.0% of people recently incarcerated.2 Those are the axes along which structural racism operates in the United States — housing, food, employment, disability, incarceration. Depression prevalence tracks the exposure, not the race category.

And in one of the most damning single numbers in the literature: any depression was present in 42.7% of people who reported experiencing discrimination in an HIV care setting, versus 32.0% of those who did not.2 The clinic itself can be an exposure. Our page on shame and stigma takes that up directly.

Long-term survivors

People who lived through the worst years of the epidemic carry a distinct constellation: bereavement on a scale most clinicians have never encountered, survivor guilt, and a future that was never planned for because it wasn't expected. Activist Tez Anderson named it AIDS survivor syndrome, describing how "many of us went down a rabbit hole, experiencing years of anger, anxiety and poor sleep with nightmares."20 The clinical picture overlaps heavily with PTSD and complicated grief, and the DHHS guidelines note that suicide risk remains greater in people with HIV than in the general population — in one French multicenter analysis, suicide was the second-highest cause of death among virologically suppressed people on ART, and social isolation combined with depression is particularly common among older adults with HIV.8 See long-term survivors for more.

Younger people living with HIV

The DHHS guidelines report that among adolescents with early-acquired HIV, nearly 70% meet criteria for a psychiatric disorder at some point in their lives, and that among adolescents and young adults presenting for care at Adolescent Trials Network sites, symptom inventories identified depression 43% of the time and anxiety 31%.8 CDC's anxiety data found the highest GAD prevalence by age in the 30–39 group, at 26.6%.3 For LGBTQ+ young people, The Trevor Project operates 24/7 by phone at 1-866-488-7386, by text to 678678, and by chat.13

Florida — resources, and one law worth understanding

Florida runs its HIV care and support programs through the Department of Health, which describes services that may include health care, dental care, transportation, case management, housing, and medication for people living with HIV who need assistance.21 Those programs are administered county by county through local health departments and contracted providers, so the practical starting point is your county health department's HIV/AIDS program — where a case manager can tell you what mental health services are available locally under Ryan White.1021 For anything urgent but non-emergency, 2-1-1 works statewide and is often the fastest route to a Florida-specific answer about which behavioral health agencies have openings.

The Baker Act, plainly

Florida's involuntary examination statute — universally called the Baker Act — is one of the most misunderstood laws in the state, and misunderstanding it keeps people from calling for help. Under section 394.463 of the Florida Statutes, a person may be taken to a receiving facility for involuntary examination only if there is reason to believe the person has a mental illness and, because of that mental illness, either has refused voluntary examination after conscientious explanation of its purpose or is unable to determine for themselves whether examination is necessary — and either, without care or treatment, is likely to suffer from neglect or refuse self-care posing a real and present threat of substantial harm not avoidable through willing family, friends, or other services; or there is a substantial likelihood the person will cause serious bodily harm to themselves or others in the near future, as evidenced by recent behavior.22

The statute is explicit that a person may not be held in a receiving facility for involuntary examination longer than 72 hours.22 Both prongs must be met — a mental illness plus the specific harm criteria. Being sad, being in treatment, having a psychiatric history, or telling a therapist you feel hopeless does not by itself meet the standard.

Florida's HIV epidemic is among the largest in the nation, and its Ryan White-funded network is correspondingly large. If you are between providers, our find care page and the state's HIV/AIDS program pages are the two fastest starting points.21

What to actually do next

If you have read this far, something on this page probably applied to you. Here is the shortest useful sequence.

1. This week: put a number on it. Find a PHQ-9 and a GAD-7 — your clinic will have them — and complete them honestly. A number is easier to bring to an appointment than a feeling, and it gives you a baseline.5
2. At your next HIV visit: say it in the first two minutes, not at the end. "Before we do labs — I want to talk about my mood. Here's my PHQ-9." Ask what mental health services the clinic can connect you to, and whether they are covered under Ryan White.10
3. Ask about interactions once, properly. Bring your full medication list, including over-the-counter products and supplements, and ask your provider to check it against the Liverpool database. Most modern integrase-based regimens need no dose adjustment with common antidepressants.89
4. If cost is the barrier, work the list. Ryan White first, then 211, a community mental health center, Open Path, then a university training clinic. One of those will land.1019
5. Add one human. A peer group, a navigator, one honest friend. SAMHSA treats peer support as a mechanism, not a nicety.14
6. Write the safety plan while you're well, and save 988 in your phone now.11
7. If it's brain fog, ask for a workup. Depression, sleep, thyroid, B12, medications, and cardiovascular risk before anyone concludes it's HAND — the criteria themselves require excluding those causes.17